Norvasl Trademark Details

Norvasl was registered on Tuesday, December 15, 1987 and is currently owned by Pfizer Inc. under the registration number 1468775 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 29 years ago on Monday, June 20, 1994, according to the United State Patent & Trademark Office

Word Mark	Norvasl
Status	Dead Registered 710 — Cancelled - Section 8

Pfizer Inc.
235 East 42nd Street
New York, Ny 10017

Serial Number	73660982
Registration Number	1468775
Status Date	Monday, June 20, 1994
Filing Date	Monday, June 20, 1994
Registration Date	Tuesday, December 15, 1987
Attorney	William J. Goebelbecker

Correspondent

WILLIAM J. GOEBELBECKER
PFIZER INC.
235 EAST 42ND STREET
NEW YORK, NY 10017

Case File Statements

Goods & Services	Pharmaceutical Preparation Having Antianginal and Antihypertensive Properties

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	018
Status	2 — Sec. 8 – Entire Registration
Status Date	Monday, June 20, 1994
First Use Anywhere	Wednesday, April 8, 1987
First Use In Commerce	Wednesday, April 8, 1987
Primary Code	005

Trademark Timeline

Apr 08 1987

First use anywhere for the mark
Apr 08 1987

First use in commerce for the mark
May 15 1987

Trademark application filed with USPTO
Jul 31 1987

Assigned To Examiner
Aug 03 1987

Approved For Pub - Principal Register
Aug 21 1987

Notice of Publication
Sep 22 1987

Published For Opposition
Dec 15 1987

Registered-Principal Register
Dec 15 1987

Trademark officially registered with the USPTO
Jun 20 1994

Cancelled Sec. 8 (6-Yr)

Norvasl Trademark Details

Correspondent

Case File Statements

Classifications

Trademark Timeline

You must be signed in to print.

Once signed in, look for the PDF button.